Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557614161> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2557614161 abstract "Abstract Abstract 4769 Background: The oxygen sensing pathway is one of the major controlling mechanisms of erythropoiesis in humans and other mammals. The transcription factor, Hypoxia-Inducible-Factor (HIF) regulates the local gene expression of the hormone erythropoietin (EPO). Degradation of HIF1α is regulated via oxygen dependent pathway by Prolyl Hydroxylases (PHDs) enzymes and the inhibition of PHD enzyme activity stimulates the erythropoietic response. The purpose of this study was to develop a mechanistic Pharmacokinetic/Pharmacodynamic (PK/PD) model to describe the effect of a Prolyl Hydroxylase Inhibitor (PHI) on the erythropoietic process in mice. Methods: PHI was given orally at three single doses of 10, 30 and 100mg/kg to male BALB/C mice (N=3-6, per time point). The blood plasma and kidney tissue samples were collected upto 96hrs. The PD markers were: kidney HIF1α concentration, kidney EPO mRNA expression, EPO plasma concentration and reticulocyte count. A two compartment model with first order absorption was fitted to describe the PK in plasma. Two different dose dependent apparent volume of distribution was assumed for the central (plasma) compartment at lower and higher doses. For the PD model, under quassi steady state assumption the enzymatic hydroxylation leading to degradation of HIF1α by PHDs is assumed to be an irreversible reaction. The drug present in plasma stimulates the removal of PHDs which results in accumulation of HIF1α and further EPO stimulation. This stimulation of kidney EPO mRNA, EPO protein level and reticulocytes were described by a cascade of indirect response models. ADAPT5 was used for all model fittings. Results: At higher PHI dose levels, ~30-40 fold increase in HIF1α was observed which caused ~1000 fold increase in EPO mRNA and EPO plasma concentrations within 6–8 hrs whereas the reticulocytes level increased by 3–4 fold within 3–5 days of single dose administration. Model parameters such as PHI elimination rate (kel, 0.43hr-1), the dose dependent apparent volume of distribution (V/F, 2–8L), the drug potency (IC50, 0.68μ M) for the degradation of PHDs; rate of loss (kout, 0.26hr-1) of HIF1α; the depletion rate of EPO mRNA (kd1, 0.48hr-1), plasma EPO (kd2, 0.25hr-1); and half maximal effective concentration (EC50, 7.01 ng/mL) of EPO for reticulocyte stimulation were estimated with high precision levels. Overall, the PK/PD model adaquetly captured the experimental data for all three doses. Conclusion: The erythropoietic process follows a cascade of biological events which is well described by the presented PK/PD model. Our model uses the systems biology approach to vertically integrate the intracellular HIF1α and EPO mRNA responses with in vivo markers of erythropoiesis such as EPO plasma levels and reticulocyte counts. Disclosures: No relevant conflicts of interest to declare." @default.
- W2557614161 created "2016-12-08" @default.
- W2557614161 creator A5017024495 @default.
- W2557614161 creator A5053414376 @default.
- W2557614161 creator A5070248454 @default.
- W2557614161 date "2010-11-19" @default.
- W2557614161 modified "2023-09-27" @default.
- W2557614161 title "A Mechanism Based Pharmacokinetic/Pharmacodynamic Model of the Effect of a Prolyl Hydroxylase Inhibitor on Erythropoietic Response In Mice" @default.
- W2557614161 doi "https://doi.org/10.1182/blood.v116.21.4769.4769" @default.
- W2557614161 hasPublicationYear "2010" @default.
- W2557614161 type Work @default.
- W2557614161 sameAs 2557614161 @default.
- W2557614161 citedByCount "0" @default.
- W2557614161 crossrefType "journal-article" @default.
- W2557614161 hasAuthorship W2557614161A5017024495 @default.
- W2557614161 hasAuthorship W2557614161A5053414376 @default.
- W2557614161 hasAuthorship W2557614161A5070248454 @default.
- W2557614161 hasConcept C104317684 @default.
- W2557614161 hasConcept C105580179 @default.
- W2557614161 hasConcept C111113717 @default.
- W2557614161 hasConcept C112705442 @default.
- W2557614161 hasConcept C126322002 @default.
- W2557614161 hasConcept C134018914 @default.
- W2557614161 hasConcept C160450060 @default.
- W2557614161 hasConcept C181199279 @default.
- W2557614161 hasConcept C185592680 @default.
- W2557614161 hasConcept C24998067 @default.
- W2557614161 hasConcept C2778248108 @default.
- W2557614161 hasConcept C2778403015 @default.
- W2557614161 hasConcept C2778534260 @default.
- W2557614161 hasConcept C2779703530 @default.
- W2557614161 hasConcept C2780091579 @default.
- W2557614161 hasConcept C2781109383 @default.
- W2557614161 hasConcept C55493867 @default.
- W2557614161 hasConcept C71924100 @default.
- W2557614161 hasConcept C86803240 @default.
- W2557614161 hasConcept C98274493 @default.
- W2557614161 hasConceptScore W2557614161C104317684 @default.
- W2557614161 hasConceptScore W2557614161C105580179 @default.
- W2557614161 hasConceptScore W2557614161C111113717 @default.
- W2557614161 hasConceptScore W2557614161C112705442 @default.
- W2557614161 hasConceptScore W2557614161C126322002 @default.
- W2557614161 hasConceptScore W2557614161C134018914 @default.
- W2557614161 hasConceptScore W2557614161C160450060 @default.
- W2557614161 hasConceptScore W2557614161C181199279 @default.
- W2557614161 hasConceptScore W2557614161C185592680 @default.
- W2557614161 hasConceptScore W2557614161C24998067 @default.
- W2557614161 hasConceptScore W2557614161C2778248108 @default.
- W2557614161 hasConceptScore W2557614161C2778403015 @default.
- W2557614161 hasConceptScore W2557614161C2778534260 @default.
- W2557614161 hasConceptScore W2557614161C2779703530 @default.
- W2557614161 hasConceptScore W2557614161C2780091579 @default.
- W2557614161 hasConceptScore W2557614161C2781109383 @default.
- W2557614161 hasConceptScore W2557614161C55493867 @default.
- W2557614161 hasConceptScore W2557614161C71924100 @default.
- W2557614161 hasConceptScore W2557614161C86803240 @default.
- W2557614161 hasConceptScore W2557614161C98274493 @default.
- W2557614161 hasLocation W25576141611 @default.
- W2557614161 hasOpenAccess W2557614161 @default.
- W2557614161 hasPrimaryLocation W25576141611 @default.
- W2557614161 hasRelatedWork W1486006387 @default.
- W2557614161 hasRelatedWork W1557694007 @default.
- W2557614161 hasRelatedWork W1600046139 @default.
- W2557614161 hasRelatedWork W190436285 @default.
- W2557614161 hasRelatedWork W1968071850 @default.
- W2557614161 hasRelatedWork W2045175150 @default.
- W2557614161 hasRelatedWork W2054412308 @default.
- W2557614161 hasRelatedWork W2057573002 @default.
- W2557614161 hasRelatedWork W2128599461 @default.
- W2557614161 hasRelatedWork W2139472237 @default.
- W2557614161 hasRelatedWork W2169754030 @default.
- W2557614161 hasRelatedWork W2388302788 @default.
- W2557614161 hasRelatedWork W2463140243 @default.
- W2557614161 hasRelatedWork W2512964162 @default.
- W2557614161 hasRelatedWork W2592983531 @default.
- W2557614161 hasRelatedWork W2993029203 @default.
- W2557614161 hasRelatedWork W3016070420 @default.
- W2557614161 hasRelatedWork W3028672708 @default.
- W2557614161 hasRelatedWork W3029202896 @default.
- W2557614161 hasRelatedWork W3029228987 @default.
- W2557614161 isParatext "false" @default.
- W2557614161 isRetracted "false" @default.
- W2557614161 magId "2557614161" @default.
- W2557614161 workType "article" @default.